Evaluation of treatment response in patients with metastatic renal cell carcinoma

Role of state-of-the-art cross-sectional imaging

Venkata Katabathina, Nathalie Lassau, Ivan Pedrosa, Chaan S. Ng, Srinivasa R. Prasad

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Recent advances in genetics and oncology have led to development of a wide array of molecular therapeutics in the management of patients with metastatic renal cell carcinoma. These drugs have revolutionized the treatment of advanced disease by significantly improving patient outcomes. State-of-the-art cross-sectional imaging techniques play a seminal role in the evaluation of treatment response by providing reproducible, objective data, thereby permitting accurate quantification of tumor burden. Evolving functional imaging techniques such as perfusion and diffusion studies continue to advance the technology beyond assessing changes in tumor size and morphology.

Original languageEnglish (US)
Pages (from-to)70-81
Number of pages12
JournalCurrent Urology Reports
Volume13
Issue number1
DOIs
StatePublished - Feb 2012

Fingerprint

Renal Cell Carcinoma
Tumor Burden
Therapeutics
Perfusion
Technology
Pharmaceutical Preparations
Neoplasms

Keywords

  • Arterial spin labeling
  • Computed tomography
  • Contrast-enhanced imaging
  • Functional imaging techniques
  • Magnetic resonance imaging
  • Metastatic renal cell carcinoma
  • Molecular therapeutics
  • Positron emission tomography
  • RECIST
  • Treatment response
  • Ultrasound

ASJC Scopus subject areas

  • Urology

Cite this

Evaluation of treatment response in patients with metastatic renal cell carcinoma : Role of state-of-the-art cross-sectional imaging. / Katabathina, Venkata; Lassau, Nathalie; Pedrosa, Ivan; Ng, Chaan S.; Prasad, Srinivasa R.

In: Current Urology Reports, Vol. 13, No. 1, 02.2012, p. 70-81.

Research output: Contribution to journalArticle

Katabathina, Venkata ; Lassau, Nathalie ; Pedrosa, Ivan ; Ng, Chaan S. ; Prasad, Srinivasa R. / Evaluation of treatment response in patients with metastatic renal cell carcinoma : Role of state-of-the-art cross-sectional imaging. In: Current Urology Reports. 2012 ; Vol. 13, No. 1. pp. 70-81.
@article{dac99b79e8994c18b73cabb9e70973ea,
title = "Evaluation of treatment response in patients with metastatic renal cell carcinoma: Role of state-of-the-art cross-sectional imaging",
abstract = "Recent advances in genetics and oncology have led to development of a wide array of molecular therapeutics in the management of patients with metastatic renal cell carcinoma. These drugs have revolutionized the treatment of advanced disease by significantly improving patient outcomes. State-of-the-art cross-sectional imaging techniques play a seminal role in the evaluation of treatment response by providing reproducible, objective data, thereby permitting accurate quantification of tumor burden. Evolving functional imaging techniques such as perfusion and diffusion studies continue to advance the technology beyond assessing changes in tumor size and morphology.",
keywords = "Arterial spin labeling, Computed tomography, Contrast-enhanced imaging, Functional imaging techniques, Magnetic resonance imaging, Metastatic renal cell carcinoma, Molecular therapeutics, Positron emission tomography, RECIST, Treatment response, Ultrasound",
author = "Venkata Katabathina and Nathalie Lassau and Ivan Pedrosa and Ng, {Chaan S.} and Prasad, {Srinivasa R.}",
year = "2012",
month = "2",
doi = "10.1007/s11934-011-0233-x",
language = "English (US)",
volume = "13",
pages = "70--81",
journal = "Current Urology Reports",
issn = "1527-2737",
publisher = "Current Science, Inc.",
number = "1",

}

TY - JOUR

T1 - Evaluation of treatment response in patients with metastatic renal cell carcinoma

T2 - Role of state-of-the-art cross-sectional imaging

AU - Katabathina, Venkata

AU - Lassau, Nathalie

AU - Pedrosa, Ivan

AU - Ng, Chaan S.

AU - Prasad, Srinivasa R.

PY - 2012/2

Y1 - 2012/2

N2 - Recent advances in genetics and oncology have led to development of a wide array of molecular therapeutics in the management of patients with metastatic renal cell carcinoma. These drugs have revolutionized the treatment of advanced disease by significantly improving patient outcomes. State-of-the-art cross-sectional imaging techniques play a seminal role in the evaluation of treatment response by providing reproducible, objective data, thereby permitting accurate quantification of tumor burden. Evolving functional imaging techniques such as perfusion and diffusion studies continue to advance the technology beyond assessing changes in tumor size and morphology.

AB - Recent advances in genetics and oncology have led to development of a wide array of molecular therapeutics in the management of patients with metastatic renal cell carcinoma. These drugs have revolutionized the treatment of advanced disease by significantly improving patient outcomes. State-of-the-art cross-sectional imaging techniques play a seminal role in the evaluation of treatment response by providing reproducible, objective data, thereby permitting accurate quantification of tumor burden. Evolving functional imaging techniques such as perfusion and diffusion studies continue to advance the technology beyond assessing changes in tumor size and morphology.

KW - Arterial spin labeling

KW - Computed tomography

KW - Contrast-enhanced imaging

KW - Functional imaging techniques

KW - Magnetic resonance imaging

KW - Metastatic renal cell carcinoma

KW - Molecular therapeutics

KW - Positron emission tomography

KW - RECIST

KW - Treatment response

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=84857635197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857635197&partnerID=8YFLogxK

U2 - 10.1007/s11934-011-0233-x

DO - 10.1007/s11934-011-0233-x

M3 - Article

VL - 13

SP - 70

EP - 81

JO - Current Urology Reports

JF - Current Urology Reports

SN - 1527-2737

IS - 1

ER -